个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
周一盘中交易时段,12只医疗保健类股走势
Gainers
- Jaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday's regular session. The current volume of 532.2K shares is 6.8% of Jaguar Health's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $808.9 million.
- Intelligent Bio Solutions (NASDAQ:INBS) stock increased by 424.84% to $1.38. As of 12:30 EST, Intelligent Bio Solutions's stock is trading at a volume of 115.7 million, which is 206846.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.2 million.
- Pliant Therapeutics (NASDAQ:PLRX) stock rose 46.3% to $32.93. Trading volume for this security as of 12:30 EST is 9.7 million, which is 2479.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.6 billion.
- ThermoGenesis Holdings (NASDAQ:THMO) stock increased by 22.56% to $4.02. Trading volume for this security as of 12:30 EST is 247.2K, which is 273.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.1 million.
- Vaxxinity (NASDAQ:VAXX) stock increased by 22.49% to $3.67. Vaxxinity's stock is trading at a volume of 4.5 million shares as of 12:30 EST. This is 1312.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $463.2 million.
- Candel Therapeutics (NASDAQ:CADL) shares increased by 21.42% to $2.89. Trading volume for Candel Therapeutics's stock is 91.7K as of 12:30 EST. This is 174.9% of its average full-day volume over the last 100 days. The company's market cap stands at $83.5 million.
Losers
- Catalyst Pharmaceuticals (NASDAQ:CPRX) shares decreased by 33.0% to $13.94 during Monday's regular session. Trading volume for Catalyst Pharmaceuticals's stock is 11.1 million as of 12:30 EST. This is 475.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.4 billion.
- RenovoRx (NASDAQ:RNXT) shares fell 20.47% to $2.58. Trading volume for RenovoRx's stock is 123.2K as of 12:30 EST. This is 366.9% of its average full-day volume over the last 100 days. The company's market cap stands at $23.5 million.
- Akanda (NASDAQ:AKAN) shares fell 18.13% to $0.18. Akanda's stock is trading at a volume of 2.1 million shares as of 12:30 EST. This is 254.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.9 million.
- AnPac Bio-Medical Science (NASDAQ:ANPC) shares decreased by 17.3% to $7.96. The market value of their outstanding shares is at $324.8 million.
- Tricida (NASDAQ:TCDA) shares declined by 16.84% to $0.1. Tricida's stock is trading at a volume of 20.2 million shares as of 12:30 EST. This is 134.6% of its average full-day volume over the last 100 days. The company's market cap stands at $5.7 million.
- Avalo Therapeutics (NASDAQ:AVTX) stock declined by 16.54% to $4.09. The company's market cap stands at $38.5 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
获胜者
- Jaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday's regular session. The current volume of 532.2K shares is 6.8% of Jaguar Health's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $808.9 million.
- Intelligent Bio Solutions (NASDAQ:INBS) stock increased by 424.84% to $1.38. As of 12:30 EST, Intelligent Bio Solutions's stock is trading at a volume of 115.7 million, which is 206846.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.2 million.
- Pliant Therapeutics (NASDAQ:PLRX) stock rose 46.3% to $32.93. Trading volume for this security as of 12:30 EST is 9.7 million, which is 2479.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.6 billion.
- ThermoGenesis Holdings (NASDAQ:THMO) stock increased by 22.56% to $4.02. Trading volume for this security as of 12:30 EST is 247.2K, which is 273.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.1 million.
- Vaxxinity (NASDAQ:VAXX) stock increased by 22.49% to $3.67. Vaxxinity's stock is trading at a volume of 4.5 million shares as of 12:30 EST. This is 1312.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $463.2 million.
- Candel Therapeutics (NASDAQ:CADL) shares increased by 21.42% to $2.89. Trading volume for Candel Therapeutics's stock is 91.7K as of 12:30 EST. This is 174.9% of its average full-day volume over the last 100 days. The company's market cap stands at $83.5 million.
- 捷豹健康 纳斯达克股票代码:JAGX)股价在周一的例会上上涨6215.8%,至5.35美元。目前532.2万股的交易量是Jaguar Health过去100天(上次更新时间为美国东部标准时间 12:30)平均全日成交量的6.8%。他们已发行股票的市值为8.089亿美元。
- 智能生物解决方案 纳斯达克股票代码:INBS)的股票上涨了424.84%,至1.38美元。截至美国东部标准时间 12:30,Intelligent Bio Solutions的股票交易量为1.157亿股,占其过去100天平均全日交易量的206846.4%。他们已发行股票的市值为2520万美元。
- Pliant Therape 纳斯达克股票代码:PLRX)股价上涨46.3%,至32.93美元。截至美国东部标准时间 12:30,该证券的交易量为970万,占其过去100天平均全日交易量的2479.0%。他们已发行股票的市值为16亿美元。
- ThermoGen 纳斯达克股票代码:THMO)的股票上涨了22.56%,至4.02美元。截至美国东部标准时间 12:30,该证券的交易量为247.2K,占其过去100天平均全日交易量的273.9%。他们已发行股票的市值为410万美元。
- Vaxxinity 纳斯达克股票代码:VAXX)的股票上涨了22.49%,至3.67美元。截至美国东部标准时间 12:30,Vaxxinity的股票交易量为450万股。这是其过去 100 天平均全日交易量的 1312.0%。他们已发行股票的市值为4.632亿美元。
- 坎德尔疗法 纳斯达克股票代码:CADL)的股价上涨了21.42%,至2.89美元。截至美国东部标准时间 12:30,Candel Therapeutics股票的交易量为9.17万。这是其过去 100 天平均全日交易量的174.9%。该公司的市值为8,350万美元。
Losers
失败者
- Catalyst Pharmaceuticals (NASDAQ:CPRX) shares decreased by 33.0% to $13.94 during Monday's regular session. Trading volume for Catalyst Pharmaceuticals's stock is 11.1 million as of 12:30 EST. This is 475.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.4 billion.
- RenovoRx (NASDAQ:RNXT) shares fell 20.47% to $2.58. Trading volume for RenovoRx's stock is 123.2K as of 12:30 EST. This is 366.9% of its average full-day volume over the last 100 days. The company's market cap stands at $23.5 million.
- Akanda (NASDAQ:AKAN) shares fell 18.13% to $0.18. Akanda's stock is trading at a volume of 2.1 million shares as of 12:30 EST. This is 254.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.9 million.
- AnPac Bio-Medical Science (NASDAQ:ANPC) shares decreased by 17.3% to $7.96. The market value of their outstanding shares is at $324.8 million.
- Tricida (NASDAQ:TCDA) shares declined by 16.84% to $0.1. Tricida's stock is trading at a volume of 20.2 million shares as of 12:30 EST. This is 134.6% of its average full-day volume over the last 100 days. The company's market cap stands at $5.7 million.
- Avalo Therapeutics (NASDAQ:AVTX) stock declined by 16.54% to $4.09. The company's market cap stands at $38.5 million. See Also:
- 催化剂制药 纳斯达克股票代码:CPRX)股价在周一的例会上下跌了33.0%,至13.94美元。截至美国东部标准时间 12:30,Catalyst Pharmicals股票的交易量为1110万股。这是其过去 100 天平均全日交易量的475.5%。他们已发行股票的市值为14亿美元。
- RenovorX 纳斯达克股票代码:RNXT)股价下跌20.47%,至2.58美元。截至美国东部标准时间 12:30,RenovorX股票的交易量为12.32万。这是其过去 100 天平均全日交易量的366.9%。该公司的市值为2350万美元。
- 阿坎达 纳斯达克股票代码:AKAN)股价下跌18.13%,至0.18美元。截至美国东部标准时间 12:30,Akanda的股票交易量为210万股。这是其过去 100 天平均全日交易量的254.6%。他们已发行股票的市值为590万美元。
- Anpac 生物医学科学 纳斯达克股票代码:ANPC)股价下跌17.3%,至7.96美元。他们已发行股票的市值为3.248亿美元。
- Tricida 纳斯达克股票代码:TCDA)股价下跌16.84%,至0.1美元。截至美国东部标准时间 12:30,Tricida的股票交易量为2,020万股。这是其过去 100 天平均全日交易量的134.6%。该公司的市值为570万美元。
- Avalo 疗法 纳斯达克股票代码:AVTX)股价下跌16.54%,至4.09美元。该公司的市值为3,850万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!